22 July 2024 : Clinical Research
Comparative Analysis of Antihypertensive and Anticonvulsant Regimens in Managing Pre-eclampsia and Eclampsia: Insights from a Sudanese Retrospective Study
Qusay O. Abdalla
12ABCDEF, Esraa O. Mohammed 23ABCDEFG, Wajid Syed 4ABCDEFG, Ayesha Iqbal56ACFG, Mahmood Basil A. Al-Rawi7BCFG, Bashir A. Yousef 8ABCDEF*
DOI: 10.12659/MSM.944985
Med Sci Monit 2024; 30:e944985
Table 3 Drugs used in the management of preeclampsia and eclampsia.
| Drug | Number of patients who use it (frequency %) | Dose | Number of patients use it |
|---|---|---|---|
| Nifedipine | 112 (60.5) | 10 mg BID | 10 |
| 20 mg BID | 102 | ||
| Magnesium sulfate | 110 (59.4) | ||
| Hydralazine | 110 (59.4) | ||
| Atenolol | 42 (22.7) | 50 mg OD | 30 |
| 100 mg OD | 12 | ||
| Amlodipine | 56 (30.2) | 5 mg OD | 16 |
| 10 mg OD | 40 | ||
| Aspirin | 4 (2.1) | 100–75 mg OD | |
| Methyldopa | 25 (13.5) | 250 mg TID | 22 |
| 500 mg TID | 3 | ||
| Labetalol | 7 (3.8) | ||
| Losartan | 1 (.5) | 50 mg OD | |
| Diazepam | 8 (4.3) | ||
| Phenytoin | 2 (1.1) | 250 mg | 1 |
| 500 mg | 1 | ||
| Carbamazepine | 1 (.5) | 200 mg OD | 1 |